Cargando…

Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of (131)I during radioiodine therapy of Graves’ disease

AIM: Radioiodine therapy (RIT) may trigger the development of Graves’ ophthalmopathy (GO) or exacerbate pre-existing subclinical GO. Therefore, glucocorticoid administration is recommended for patients with pre-existing GO. Aim of this study was to analyze the influence of glucocorticoid therapy wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Happel, C., Kranert, W. T., Gröner, D., Baumgarten, J., Halstenberg, J., Bockisch, B., Sabet, A., Grünwald, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211592/ https://www.ncbi.nlm.nih.gov/pubmed/33439464 http://dx.doi.org/10.1007/s12020-020-02593-x

Ejemplares similares

The influence of thionamides on intra-thyroidal uptake of (131)I during radioiodine-131 treatment of Graves’ disease
por: Happel, Christian, et al.
Publicado: (2023)

The influence of thyroid hormone medication on intra-therapeutic half-life of (131)I during radioiodine therapy of solitary toxic thyroid nodules
por: Happel, Christian, et al.
Publicado: (2022)

A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism
por: Doi, Suhail AR, et al.
Publicado: (2001)

Primary autoimmune thrombocytopenia and co-existing Graves’ disease: Role of radioiodine-131
por: Jung, Rayamajhi Sampanna, et al.
Publicado: (2014)

Analysis of risk factors of rapid thyroidal radioiodine-131 turnover in Graves’ disease patients
por: Zhang, Ruiguo, et al.
Publicado: (2017)

Radioiodination and Purification of [(131)I]β-CIT and [(131)I]FP-CIT with an Automated Radiosynthesizer
por: Plhak, Elisabeth, et al.
Publicado: (2022)

Effects of drugs on the efficacy of radioiodine ((131)|) therapy in hyperthyroid patients
por: Oszukowska, Lidia, et al.
Publicado: (2010)

Treatment failure in hyperthyroid cats after radioiodine (I‐131) injection
por: Mullowney, Deirdre, et al.
Publicado: (2021)

Apoptosis gene reprograming of human peripheral blood mononuclear cells induced by radioiodine-131 ((131)I) irradiation
por: Li, Jian-Fang, et al.
Publicado: (2019)

Biokinetic model of radioiodine I-131 in nine thyroid cancer patients subjected to in-vivo gamma camera scanning: A simplified five-compartmental model
por: Huang, Chao-Chun, et al.
Publicado: (2020)

Radiosensitive effect of curcumin on thyroid cancer cell death induced by radioiodine-131
por: Hosseinimehr, Seyed Jalal, et al.
Publicado: (2014)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
por: Hong, Chae Moon, et al.
Publicado: (2017)

Improving (131)I Radioiodine Therapy By Hybrid Polymer-Grafted Gold Nanoparticles
por: Le Goas, Marine, et al.
Publicado: (2019)

Disorders of Dental Hard Tissues Induced by Radioiodine-131 (I-131) Therapy Used in Differentiated Thyroid Cancer: An In Vitro Study
por: Mester, Alexandru, et al.
Publicado: (2020)

Adverse Reactions to Radioiodine 131I Therapy of Goiter in West African Tertiary Hospital
por: Onimode, Yetunde A., et al.
Publicado: (2016)

Predictors of euthyreosis in hyperthyroid patients treated with radioiodine (131)I(−): a retrospective study
por: Stachura, Albert, et al.
Publicado: (2020)

The Side Effects of Therapeutic Radioiodine-131 on the Structure of Enamel and Dentin in Permanent Human Teeth
por: Mester, Alexandru, et al.
Publicado: (2021)

Radioiodination of Modified Porous Silica Nanoparticles as a Potential Candidate of Iodine-131 Drugs Vehicle
por: Prihatiningsih, Maria Christina, et al.
Publicado: (2022)

Radioiodine (131I) treatment decision-making for low- and intermediate-risk differentiated thyroid cancer
por: Gao, Haiyan, et al.
Publicado: (2023)

The false-positive radioiodine I-131 uptake in the foreign body granuloma located in gluteal adipose tissue
por: Gültekin, Salih Sinan, et al.
Publicado: (2011)

Radioiodine Accumulation in a Giant Ovarian Cystadenofibroma Detected Incidentally by 131-I Whole Body Scans
por: Mebarki, Mohammed, et al.
Publicado: (2012)

Radioiodine ((131)I) therapy in a child with autism spectrum disorder: A complex and demanding task
por: Bibbo, Giovanni, et al.
Publicado: (2019)

Post-radioiodine management of patients with Graves' disease
por: Collins, K, et al.
Publicado: (2012)

Radioiodine therapy and Graves’ disease – Myths and reality
por: Plazinska, Maria Teresa, et al.
Publicado: (2020)

Radioiodine Therapy of Graves' Disease and the Uptake Paradox
por: Malapure, Sumeet Suresh, et al.
Publicado: (2020)

Predictive value of pyramidal lobe, percentage thyroid uptake and age for ablation outcome after 15 mCi fixed dose of radioiodine-131 in Graves’ disease
por: Zaman, Maseeh uz, et al.
Publicado: (2015)

Radioiodine Contamination Artifacts and Unusual Patterns of Accumulation in Whole-body I-131 Imaging: A Case Series
por: Ozcan Kara, Pelin, et al.
Publicado: (2014)

Autonomous Functioning Thyroid Nodule in a 4-year-old Male Child Treated with Radioiodine (I-131)
por: Khare, Abhishek, et al.
Publicado: (2013)

Radioiodine-131 Therapy Used for Differentiated Thyroid Cancer Can Impair Titanium Dental Implants: An In Vitro Analysis
por: Piciu, Doina, et al.
Publicado: (2023)

Development of [(131)I]I-EOE-TPZ and [(131)I]I-EOE-TPZMO: Novel Tirapazamine (TPZ)-Based Radioiodinated Pharmaceuticals for Application in Theranostic Management of Hypoxia
por: Elsaidi, Hassan, et al.
Publicado: (2019)

Radioiodine Thyroid Ablation in Graves’ Hyperthyroidism: Merits and Pitfalls
por: Nwatsock, J. F., et al.
Publicado: (2012)

Prediction of thyroidal (131)I effective half-life in patients with Graves' disease
por: Zhang, Ruiguo, et al.
Publicado: (2017)

The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease
por: Fang, Ya, et al.
Publicado: (2021)

Utility of Iodine-131 hybrid SPECT-CT fusion imaging before high-dose radioiodine therapy in papillary thyroid carcinoma
por: Bhattacharya, Anish, et al.
Publicado: (2010)

Ultrasonography Echotexture as a surrogate for Sialadenitis secondary to 131I Radioiodine Therapy for differentiated Thyroid Cancer: a review and metaanalysis
por: Lima, Graziele Aparecida Simões, et al.
Publicado: (2020)

Thyroid Cancer after Exposure to Radioiodine in Childhood and Adolescence: (131)I-Related Risk and the Role of Selected Host and Environmental Factors
por: Zupunski, Ljubica, et al.
Publicado: (2019)

MON-443 SPECT/CT Localization of Incidental Diverticular Bleed After Radioiodine (i(131)) Therapy for Metastatic Thyroid Cancer
por: Doshi, Sejal B, et al.
Publicado: (2020)

Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study
por: Weber, Manuel, et al.
Publicado: (2022)

Radioiodine Therapy-Induced Conversion of Toxic Adenoma to Graves’ Disease
por: Rehman, Anis, et al.
Publicado: (2020)

Should radioiodine now be first line treatment for Graves’ disease?
por: Okosieme, Onyebuchi E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qr9789p6r2i399a9pqluuqe5om